Russia scores points with vaccine diplomacy, but snags arise
MOSCOW (AP) — Russia's boast in August that it was the first country to authorize a coronavirus vaccine led to skepticism at the time because of its insufficient testing. Six months later, as demand for the Sputnik V vaccine grows, experts are raising questions again — this time, over whether Moscow can keep up with all the orders from the countries that want it.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
